Ping An Biomedical Co., Ltd. income statement PASW

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, Ping An Biomedical Co., Ltd. reported revenue of $4.8 million. It recorded a net loss of $1.8 million. The operating loss came to $2.1 million, an operating margin of -43.1%. Diluted earnings per share were -$0.10.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2025
Sep 30, 2025
Revenue
5
Cost of revenue
5
Gross profit
0
Selling, general and administrative
1
Operating income
-2
Interest income
0
Interest expense
0
Other income (expense)
0
Pretax income
-2
Income tax
0
Net income
-2
Basic EPS
-0.10
Diluted EPS
-0.10
Weighted average shares, basic
18
Weighted average shares, diluted
18
Other measures
Depreciation and amortization
0
EBITDA
-2
Interest coverage
-47.88x
Margins
Gross margin
2.78%
Operating margin
-43.05%
Pretax margin
-43.00%
Profit margin
-37.57%
EBITDA margin
-43.04%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300)
Listed as
PASW (Nasdaq)
Incorporated in
Cayman Islands
Headquarters
Cheung Sha Wan, Kowloon
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1897532
Former names
Majestic Ideal Holdings Ltd (until Sep 29, 2025)

Other Apparel & Other Finishd Prods of Fabrics & Similar Matl companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.